Net sales dropped sharply year-over-year, but losses narrowed and the order backlog grew. A major rights issue was launched to fund projects, and the subsidiary shifted focus to PFAS water purification, with the first treatment raft entering production.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.